Zolmitriptan Spray
Product Images NDC 63629-9575

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Zolmitriptan (NDC 63629-9575). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
This is a table showing different nasal sprays and their estimated probability of response in percentage, over a period of hours from the initial dose. The nasal sprays mentioned are © 25 MG, A 50MG, and a placebo.*
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
This is a chart showing the estimated probability of taking an escape medication in percentage after using different nasal sprays and a placebo. The nasal sprays are labeled as Basigsase at 25 NG and 55.0 MG. The chart tracks the probability over a period of 11 hours from the initial dose. The percentages range from 0 to 2%.*
FDA Label Image

Figure 3 (Image 03)

Figure 3 (Image 03)
This appears to be a study on the effectiveness of Zolmitriptan 5 mg versus a placebo in reducing the likelihood of needing rescue medication. The study included 231 participants who took Zolmitriptan and 253 participants who took the placebo. The text also mentions an estimated probability of needing rescue medication over a certain timeframe, but the specifics are not clear.*
FDA Label Image

Figure-a (Image 04)

FDA Label Image

Figure B (Image 05)

FDA Label Image

Figure-c (Image 06)

FDA Label Image

Figure D (Image 07)

FDA Label Image

Chemical-structure (Image 10)

FDA Label Image

Label (Lbl636299575)

Label (Lbl636299575)
This is a description of a nasal spray called Zolmitriptan Nasal Spray, USP used for intranasal use. Each spray contains 5 mg of Zolmitriptan in a 100-pL buffered solution. The normal dosage and instructions have to be acquired from the prescribing information that comes with the product. The nasal spray has to be stored within a specific temperature range of 20° to 25°C (68° to 77°F), and it is essential to keep it away from children. The NDC number is 63629-9575-01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.